The global medical industry experienced a 34% decline in the number of 3D printing-related patent applications in Q3 2024 compared with the previous quarter. The total number of 3D printing-related grants dropped by 10% in Q3 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook ³Ô¹ÏºÚÁÏÍøs: Patents Trends Q3 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Notably, the number of 3D printing-related patent applications in the medical industry was 331 in Q3 2024, versus 499 in the prior quarter.
The top five companies accounted for 13% of patenting activity
³Ô¹ÏºÚÁÏÍø of patenting activity by companies shows that Align Technology filed the most 3D printing patents within the medical industry in Q3 2024. The company filed 18 3D printing-related patents in the quarter, compared with 12 in the previous quarter. It was followed by Johnson & Johnson with 9 3D printing patent filings, Carlsmed (7 filings), and Stryker (5 filings) in Q3 2024.
Patenting activity was driven by the US with a 35% share of total patent filings
The largest share of 3D printing related patent filings in the medical industry in Q3 2024 was in the US with 35%, followed by China (14%) and Japan (6%). The share represented by the US was 6% higher than the 28% share it accounted for in Q2 2024.
For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs: Patents Trends Q3 2024,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.